Perspective Historical Income Statement
| CATX Stock | 4.35 0.23 5.58% |
Historical analysis of Perspective Therapeutics income statement accounts such as Total Revenue of 1.4 M, Gross Profit of 1.3 M or Other Operating Expenses of 44.5 M can show how well Perspective Therapeutics performed in making a profits. Evaluating Perspective Therapeutics income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Perspective Therapeutics's future profits or losses.
Financial Statement Analysis is much more than just reviewing and examining Perspective Therapeutics latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Perspective Therapeutics is a good buy for the upcoming year.
Perspective |
About Perspective Income Statement Analysis
Perspective Therapeutics Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Perspective Therapeutics shareholders. The income statement also shows Perspective investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).
Perspective Therapeutics Income Statement Chart
Add Fundamental
Total Revenue
Total revenue comprises all receipts Perspective Therapeutics generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.Other Operating Expenses
Other Operating Expenses is the expense which generally does not depend on sales or production quantities of Perspective Therapeutics. It is also known as Perspective Therapeutics overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.Cost Of Revenue
Cost of Revenue is found on Perspective Therapeutics income statement and represents the costs associated with goods and services Perspective Therapeutics provides. Indirect cost, such as salaries, is not included. In other words, cost of revenue is the total cost incurred to obtain a sale. It is more than the traditional cost of goods sold, since it includes specific selling and marketing activities.Total Operating Expenses
The total costs associated with the day-to-day operations of a business, excluding the cost of goods sold but including selling, general, and administrative expenses.Income Before Tax
Income Before Tax which can also be referred as pre-tax income is reported on Perspective Therapeutics income statement and is an important metric when analyzing Perspective Therapeutics profitability. Accounting techniques because taxes can be complex, and not perfectly consistent from one company to company, an analyst may use pre-tax income as a more stable measure of profitability.Most accounts from Perspective Therapeutics' income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Perspective Therapeutics current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Perspective Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. For more information on how to buy Perspective Stock please use our How to Invest in Perspective Therapeutics guide.At this time, Perspective Therapeutics' Depreciation And Amortization is fairly stable compared to the past year. Other Operating Expenses is likely to rise to about 44.5 M in 2024, whereas Total Revenue is likely to drop slightly above 1.4 M in 2024.
| 2021 | 2022 | 2023 | 2024 (projected) | Total Operating Expenses | 18.2M | 17.4M | 42.4M | 44.5M | Cost Of Revenue | 6.2M | 5.5M | 4.9M | 4.2M |
Perspective Therapeutics income statement Correlations
Click cells to compare fundamentals
Perspective Therapeutics Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Perspective Therapeutics income statement Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Depreciation And Amortization | 147K | 9K | 248K | 344K | 981K | 1.0M | |
| Total Revenue | 9.7M | 10.1M | 10.8M | 7.1M | 1.4M | 1.4M | |
| Gross Profit | 5.1M | 5.1M | 4.6M | 1.6M | 1.4M | 1.3M | |
| Other Operating Expenses | 13.2M | 13.5M | 18.2M | 22.9M | 42.4M | 44.5M | |
| Operating Income | (3.5M) | (3.4M) | (7.4M) | (15.2M) | (40.9M) | (38.9M) | |
| Ebit | (3.6M) | (3.4M) | (7.4M) | (15.2M) | (40.9M) | (38.9M) | |
| Ebitda | (3.5M) | (3.4M) | (7.1M) | (14.8M) | (40.0M) | (38.0M) | |
| Cost Of Revenue | 4.6M | 4.9M | 6.2M | 5.5M | 4.9M | 4.2M | |
| Total Operating Expenses | 8.6M | 8.6M | 18.2M | 17.4M | 42.4M | 44.5M | |
| Income Before Tax | (3.4M) | (3.4M) | (7.3M) | (14.7M) | (40.1M) | (38.1M) | |
| Total Other Income Expense Net | 30K | 50K | 119K | 512K | 835K | 876.8K | |
| Net Income | (3.3M) | (3.2M) | (7.3M) | (14.7M) | (46.5M) | (44.2M) | |
| Income Tax Expense | (294K) | (177K) | (199K) | (119K) | (2.7M) | (2.5M) | |
| Interest Expense | 29K | 30K | 50K | 119K | 84K | 89.8K | |
| Selling General Administrative | 4.6M | 4.7M | 9.4M | 10.9M | 21.0M | 22.0M | |
| Selling And Marketing Expenses | 3.0M | 2.4M | 2.8M | 3.2M | 97K | 92.2K | |
| Research Development | 1.1M | 1.4M | 2.6M | 2.6M | 21.3M | 22.4M | |
| Net Interest Income | 30K | 59K | 119K | 850K | 977.5K | 1.0M | |
| Interest Income | 30K | 59K | 119K | 934K | 1.1M | 1.1M | |
| Net Income From Continuing Ops | (3.4M) | (3.4M) | (7.3M) | (37.5M) | (33.7M) | (32.0M) | |
| Reconciled Depreciation | 147K | 149K | 248K | 946K | 1.1M | 1.1M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Perspective Stock Analysis
When running Perspective Therapeutics' price analysis, check to measure Perspective Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Perspective Therapeutics is operating at the current time. Most of Perspective Therapeutics' value examination focuses on studying past and present price action to predict the probability of Perspective Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Perspective Therapeutics' price. Additionally, you may evaluate how the addition of Perspective Therapeutics to your portfolios can decrease your overall portfolio volatility.